Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Viatris Inc recalls Levothyroxine Sodium Tablets USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Superpotent Drug and Subpotent Drug: potency failures obtained
Products
  • Levothyroxine Sodium Tablets USP
Where it was sold

Nationwide within the United States and Puerto Rico

Nationwide

Units affected
34,845 bottes
About this recall
Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.